InvestorsHub Logo
Followers 6
Posts 323
Boards Moderated 0
Alias Born 08/23/2021

Re: None

Saturday, 11/06/2021 10:52:25 PM

Saturday, November 06, 2021 10:52:25 PM

Post# of 50140
"Earnings priced in due to dilution" says our financial expert after the stock is down 90-92% YTD due to uh, 40-50% dilution?
And that is with "the story" while certainly being less attractive than with 170+ beds, having kept improving ever since this was revived with only the hope of the treatment center acquisition, to a now promise of actual revenue showing up on the balance sheet.
I mean in pure fundamentals there's all the things needed for this to double in pps and still be reasonably discounted.
Bubae is just the kind of guy that will tell you to not buy 99% of tickers because they have a little bit too much debt and won't be reasonably able to pay it back in a couple years.
You buy OTC. You accept OTC shenanigans.
I'm infinitely more comfortable holding stock in a company with actual assets than some nearly defunct pharma company with a couple probably fraudulent patents in its belt or whatever trash gets pumped these days.
That said this week has been good to me, brought down my average to 0.0018 and I'm planning to get it around 0.0016 if I keep getting gifted with discounts
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GRST News